Found 5 matching trials
CD19 Redirected Autologous T Cells for Hodgkin Lymphoma EARLY_PHASE1 Pilot open-label study to estimate the feasibility, safety and efficacy of ...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells in Patients With Refractory or Relapsed Hodgkin Lymphoma EARLY_PHASE1 Pilot open-label study to estimate the feasibility, safety and efficacy of ...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma PHASE1 This is an open-label phase1 study to assess the safety and efficacy of U01...
Show More Location
Shanghai Tongji Hospital ( Tongji Hospital of Tongji University)
Learn More & Join Trial
Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial PHASE2 This is a prospective, open-label, single-arm, umbrella phase 2 clinical tr...
Show More Location
Multiple Locations
Learn More & Join Trial
Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma PHASE1 This is a Phase I trial to assess the safety and feasibility of administeri...
Show More Location
Multiple Locations
Learn More & Join Trial